Clinical trials recruiting in Tokyo, Koto-ku, Japan

Phase breakdown

Conditions recruiting in Tokyo, Koto-ku, Japan

Recruiting trials in Tokyo, Koto-ku, Japan

• Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
  NCT06324357 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
  NCT07195695 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
  NCT05882058 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tokyo, Koto-ku, Japan?

3 recruiting trials have at least one study site in Tokyo, Koto-ku, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.